Want to share experiences with LPR-3? DSFE launches a special interest group on LPR3. Read more


- October 15, 2021, 9:15 am

Only 11 days left for our annual meeting🥳 The topic of the year is pragmatic trials, and we look forward to welcome Mira Zuidgeest, @DanMoralesEpi and Simon Skibsted. It is still possible to sign up, just contact info@dsfe.dk.
h J R

- October 15, 2021, 9:09 am

Our LPR3 platform is up running and it is free to join independent of DSFE membership. Contact info@dsfe.dk if you'll like to join the community. Though not required, you can be DSFE member through our website and be part of our active pharmaepi society.
h J R

- September 27, 2021, 11:30 am

TIP: Colleagues from OPEN, Odense University Hospital and Clinical Pharmacology, Pharmacy and Environmental Medicine made a do-file on combining LPR2 and LPR3 data, now available at our newly lauched LPR3 SIG platform. What a contribution! Thank you @MetteBliddal!
h J R

- September 15, 2021, 4:45 am

Today we lauch the new LPR3 Special Interest Group where DSFE members can help each other handle LPR3 data 🥳 Sign up today and you are ready to ask questions, share codes and help colleagues. More info at https://t.co/Dswwhb1e8Q
h J R

- September 7, 2021, 6:43 am

Are you working with LPR3 data? Why reinvent the wheel -join DSFEs new SIG where members online can share LPR3 coding, discuss obstacles and help each other. Contact info@dsfe.dk to sign up!
h J R

Upcoming events:

Information and material from previous meetings can be found here.

DSFE annual meeting 2021 @ Online
Oct 26 @ 12:30 PM – 4:30 PM

Theme “Pragmatic trials: academic, regulatory, and industry perspective”.
Whereas the traditional randomized controlled trial is designed to establish efficacy of a specific drug, i.e. the effect under ideal conditions, the pragmatic trial is designed to establish effectiveness, i.e. how well the drug works in everyday clinical practice. To present the topic from different angles, we have invited speakers from regulatory agencies, academia, and the industry including Mira G.P. Zuidgeest and Simon Skibsted.
Please sign up by sending an email to info@dsfe.dk, no later than October 20th. We hope as many of you as possible are able to participate and we are looking forward to see you!

Link to more information

One-day course: Intermediate methods in pharmacoepidemiology @ Online
Nov 4 @ 9:30 AM – 4:00 PM

The Danish Society for Pharmacoepidemiology is offering a one-day course on “Intermediate Methods in Pharmacoepidemiology”, on November 4th, 2021. The course is held online and is free of charge for DSFE members. The course focuses on ways to control for confounding including use of propensity scores, through active comparator new user designs, self-controlled design and the use of instrumental variable analysis. The course will close with a lecture on validation methods. We are fortunate that a number of very skilled researchers and excellent lecturers have accepted to teach the course.
To register, please send an email to info@dsfe.dk, no later than November 1th.

Link to more information


The Danish Society for Pharmacoepidemiology’s purpose is to promote the development of pharmacoepidemiology in Denmark in order to contribute to the appropriate use of medicines.


The Danish Society for Pharmacoepidemiology will seek to contribute to undergraduate and postgraduate education and information of relevant professionals on pharmacoepidemiology.


The Danish Society for Pharmacoepidemiology will seek to expand Danish research internationally and participate in international cooperation to promote pharmacoepidemiology.

Scroll to top